Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).
Nat Med. 2022 Jan;28(1):96-103. doi: 10.1038/s41591-021-01634-w. Epub 2022 Jan 13.
Nat Med. 2022.
PMID: 35027752
Clinical Trial.